Menu
Global
简体中文
繁体中文
English
Home
About Us
Company Introduction
Development History
Leadership Team
Honor and Qualification
Industry Chain
Corporate Culture
R & D
Therapeutic Area
Technology Platform
Innovative Pipeline
Partnering
Products
Oncology
Digestive
NASH
Investor
Stock Information
Announcements and Circulars
Financial Report
Corporate governance
Investor Calendar
Company Information
Prospectus
Investor Relations
News
Contact Us
Address
Contact Information
Adverse drug reaction report
Join XZenith
Our Culture
Careers
Benefit
Talent Development
Employee style
News center
Enterprise dynamics
Corporate News
All
2019
2020
2021
2022
2023
2024
2025
06-26
2026
Honors | Xuanzhu Biotech Selected as one
Recently, the "2026 China Top 100 Pharmaceutical Innovation Enterprises" list was official...
06-02
2026
Expanding Frontiers and Innovating Toget...
Recently, the "National Researchers' Meeting and Project Launch Event for Phase III Clinica...
04-20
2026
The 2026 edition of the "China Expert Co...
Recently, the "China Expert Consensus on Rational Use of Acid Suppressants in Elderly Patients ...
04-09
2026
Xuanzhu Biotech has established licensin...
On April 9, 2026, Xuanzhu Biotech Co., Ltd. (hereinafter referred to as "Xuanzhu Biotech")...
04-08
2026
2026 AACR Annual Conference Preview | Xu
The 2026 Annual Meeting of the American Association for Cancer Research (AACR) will be grandly h...
<
1
2
3
4
>
Home
About Us
+
Company Introduction
Development History
Leadership Team
Honor and Qualification
Industry Chain
Corporate Culture
R & D
+
Therapeutic Area
Technology Platform
Innovative Pipeline
Partnering
Products
+
Oncology
Digestive
NASH
Investor
+
Stock Information
Announcements and Circulars
Financial Report
Corporate governance
Investor Calendar
Company Information
Prospectus
Investor Relations
News
+
Contact Us
+
Address
Contact Information
Adverse drug reaction report
Join XZenith
+
Our Culture
Careers
Benefit
Talent Development
Employee style